| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8528515 | Clinical Therapeutics | 2017 | 7 Pages |
Abstract
Doses as low as 25 µg/d of rhPTH(1-84) are well tolerated and may be effective for a subset of patients. ClinicalTrials.gov identifier: NCT01268098.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
John P. MD, Bart L. MD, Michael MD, Jeffrey MD, Tamara MD, Hak-Myung PhD, Alan MD,